FDA Continues To Report Banned Antibiotics In Indian Shrimp

The U.S. Food and Drug Administration (FDA) has released information for entry line refusals for the month of March.  The agency reported refusing a total of 208 seafood entry lines last month.  Of these, 17 (8.2%) were of shrimp entry lines refused for reasons related to banned antibiotics.

The number of shrimp entry lines refused for banned antibiotics last month was more than the double the total amount of shrimp entry lines refused for this reason in January and February combined.

The seventeen entry line refusals in March involved seven companies from three different countries and were reported by six different regional offices of the FDA:

To read the rest of the story, please go to: Southern Shrimp Alliance